Unknown

Dataset Information

0

Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward.


ABSTRACT: Patients with respiratory infections are often managed presumptively until confirmation of infection status. We assessed the impact of introducing the Enigma® MiniLab™ FluAB-RSV point-of-care test (POCT) on patients admitted with a suspected respiratory virus driven illness in an acute pediatric ward. This utilized a before and after design (respiratory viral seasons 2013/14 versus 2014/15). Following POCT implementation, oseltamivir prescribing increased in patients with influenza (OR?=?12.7, P?=?0.05, 95% CI [1.0, 153.8]). A reduction in the average reimbursement charges without a change in the length of stay was observed. Modeling suggested that laboratory test cost savings could be achieved if the POCT cost £30 and was used for screening, followed by the respiratory viral panel for RSV and influenza negative patients. A rapid POCT for influenza A/B and RSV infections in pediatric inpatients may improve oseltamivir prescribing, strengthen antimicrobial stewardship, reduce reimbursement charges and decrease laboratory costs.

SUBMITTER: Vecino-Ortiz AI 

PROVIDER: S-EPMC7125905 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Impact of a multiplex PCR point-of-care test for influenza A/B and respiratory syncytial virus on an acute pediatric hospital ward.

Vecino-Ortiz Andres I AI   Goldenberg Simon D SD   Douthwaite Sam T ST   Cheng Chih-Yuan CY   Glover Rebecca E RE   Mak Catherine C   Adams Elisabeth J EJ  

Diagnostic microbiology and infectious disease 20180404 4


Patients with respiratory infections are often managed presumptively until confirmation of infection status. We assessed the impact of introducing the Enigma® MiniLab™ FluAB-RSV point-of-care test (POCT) on patients admitted with a suspected respiratory virus driven illness in an acute pediatric ward. This utilized a before and after design (respiratory viral seasons 2013/14 versus 2014/15). Following POCT implementation, oseltamivir prescribing increased in patients with influenza (OR = 12.7, P  ...[more]

Similar Datasets

| S-EPMC6720028 | biostudies-other
| S-EPMC3122825 | biostudies-literature
| S-EPMC7430145 | biostudies-literature
| S-EPMC9563105 | biostudies-literature
| S-EPMC2709894 | biostudies-literature
| S-EPMC4634247 | biostudies-other
| S-EPMC387552 | biostudies-literature
| S-EPMC5368990 | biostudies-literature
| S-EPMC8668494 | biostudies-literature
| S-EPMC8237866 | biostudies-literature